Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 6/20 | 0.36 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6805820 | 0.93 | SPHK1 (0.42) | CYP3A4CA1SPHK1FDPS | |
| SCHEMBL118939 | 0.91 | SPHK1 (0.45) | CYP3A4SPHK1 | |
| SCHEMBL11800205 | 0.91 | SPHK1 (0.45) | CYP3A4SPHK1 | |
| SCHEMBL11801890 | 0.91 | SPHK1 (0.45) | CYP3A4SPHK1 | |
| SCHEMBL7567092 | 0.91 | SPHK1 (0.45) | CYP3A4SPHK1 | |
| SCHEMBL11798137 | 0.91 | SPHK1 (0.45) | CYP3A4SPHK1 | |
| SCHEMBL21325717 | 0.91 | SPHK1 (0.37) | ALDH1A1TSHRCYP3A4CA2CA1 | |
| SCHEMBL27188579 | 0.86 | SPHK1 (0.43) | CYP3A4CA2CA1SPHK1PLA2G2C | |
| SCHEMBL20632266 | 0.86 | TSHR (0.36) | TSHRTDP1SMN1; SMN2 | |
| SCHEMBL2058301 | 0.86 | TSHR (0.36) | TSHRTDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2860170-B1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | OSAKA ORGANIC CHEMICAL IND LTD (JP) | 2019-08-28 | — | — | EP | disclosed |
| EP-3015449-B1 | (METH)ACRYLATE PRODUCTION SYSTEM | OSAKA ORGANIC CHEMICAL IND LTD (JP) | 2018-10-10 | — | — | EP | disclosed |
| CN-105339341-B | Production system for (meth) acrylic acid ester | 大阪有机化学工业株式会社 | 2018-02-13 | — | — | CN | disclosed |
| US-9670129-B2 | Process for preparing 4-hydroxybutyl acrylate | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2017-06-06 | — | — | US | disclosed |
| US-20160136538-A1 | (METH)ACRYLATE PRODUCTION SYSTEM | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2016-05-19 | — | — | US | disclosed |
| EP-3015449-A1 | (METH)ACRYLATE PRODUCTION SYSTEM | Osaka Organic Chemical Ind., Ltd. (JP) | 2016-05-04 | — | — | EP | disclosed |
| CN-105339341-A | Production system for (meth) acrylic acid ester | OSAKA ORGANIC CHEM IND | 2016-02-17 | — | — | CN | disclosed |
| US-20150126766-A1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) | 2015-05-07 | — | — | US | disclosed |
| EP-2860170-A1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | Osaka Organic Chemical Ind., Ltd. (JP) | 2015-04-15 | — | — | EP | disclosed |
| CN-104220413-A | Method for producing 4-hydroxybutyl acrylate | OSAKA ORGANIC CHEM IND | 2014-12-17 | — | — | CN | disclosed |
| EP-0906902-B1 | A method for the production of an alkylamino (meth)acrylate and apparatus therefor. | NIPPON CATALYTIC CHEM IND (JP) | 2002-08-28 | — | — | EP | disclosed |
| US-6417392-B1 | CATALYTIC ESTER INTERCHANGE OF ALKYL (METH)ACRYLATE AND ALKYLAMINO ALCOHOL; DISTILLATION OF ALKYL ALCOHOL BY-PRODUCT IN AZEOTROPIC MIXTURE WITH ALKYL (METH)ACRYLATE; PURIFICATION USING ION EXCHANGE RESIN | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-07-09 | — | — | US | disclosed |
| EP-0906902-A2 | A method for the production of an alkylamino (meth)acrylate and apparatus therefor. | NIPPON SHOKUBAI CO., LTD. (JP) | 1999-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126766-A1 | PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE | LTB4R2, LTA4H, LTB4R | ALDH1A1 261/4885TSHR 3002/4885CYP3A4 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.